RA Capital Management, L.P. 13D and 13G filings for AN2 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:27 pm Sale | 2024-12-31 | 13G | AN2 Therapeutics, Inc. ANTX | RA Capital Management, L.P. | 0 0.000% | -1,999,997 (Position Closed) | Filing |
| 2024-08-13 5:40 pm Sale | 2024-08-09 | 13G | AN2 Therapeutics, Inc. ANTX | RA Capital Management, L.P. | 1,999,997 6.700% | -3,551,298 (-63.97%) | Filing |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | AN2 Therapeutics, Inc. ANTX | RA Capital Management, L.P. | 5,551,295 18.700% | 1,777,778 (+47.11%) | Filing |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | AN2 Therapeutics, Inc. ANTX | RA Capital Management, L.P. | 3,773,517 19.500% | 106,854 (+2.91%) | Filing |
| 2022-04-08 4:31 pm Purchase | 2022-03-29 | 13G | AN2 Therapeutics, Inc. ANTX | RA Capital Management, L.P. | 3,666,663 19.600% | 3,666,663 (New Position) | Filing |